Director, Heart Failure and Transplantation
Vanderbilt University
Nashville, Tennessee, United States
Dr JoAnn Lindenfeld is currently Professor of Medicine a at Vamderbilt Unversity Heart and Vascular Institute.
She is currently the President of the Heart Failure Society of America She served on the FDA Cardiorenal Advisory FDA Circulatory Devices panel. She is actively involved in clinical research in drugs and devices for heart failure, in vascular remodeling and clotting in patients with mechanical circulatory support, and in the evaluation of medical therapy in cardiac transplantation. She is serving and has served on multiple steering committees, DSMBs, and clinical endpoint committees of many large randomized clinical trials in heart failure. She is funded by the NIH and AHA. She has published over 500 original manuscripts, reviews, and book chapters
Disclosure information not submitted.
CRT 2024 | Faculty Assignment [ECON]
Saturday, March 9, 2024
9:00 AM – 9:00 PM ET
Monday, March 11, 2024
8:00 AM – 9:20 AM ET
Monday, March 11, 2024
8:56 AM – 9:04 AM ET
Panel Discussion | Challenges Designing Clinical Trials for Heart Failures Using the MCP Devices
Monday, March 11, 2024
9:04 AM – 9:20 AM ET
State of the Art Transcatheter Intra-Atrial Shunt Device for Treatment of Heart Failure
Monday, March 11, 2024
10:48 AM – 10:56 AM ET
Panel Discussion: What Does the Future Hold for Interatrial Shunts?
Monday, March 11, 2024
11:52 AM – 12:10 PM ET
Monday, March 11, 2024
2:32 PM – 2:50 PM ET
PHARMACOLOGY FOR THE TREATMENT OF HEART FAILURE
Monday, March 11, 2024
2:50 PM – 5:15 PM ET
Keynote | Medical Therapies Across the Heart Failure Spectrum
Monday, March 11, 2024
3:05 PM – 3:20 PM ET
New and Emerging Therapies for Heart Failure with Reduced Ejection Fraction
Monday, March 11, 2024
4:08 PM – 4:16 PM ET
Monday, March 11, 2024
4:48 PM – 5:15 PM ET